Q15910 (EZH2_HUMAN) Homo sapiens (Human)
Histone-lysine N-methyltransferase EZH2 UniProtKBInterProSTRINGInteractive Modelling
746 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5);
10 identical sequences: Pongo abelii: A0A2J8S6W0; Pan troglodytes: K7C3W4, A0A803KHR1; Mandrillus leucophaeus: A0A2K6A6R9; Theropithecus gelada: A0A8D2EC40; Macaca nemestrina: A0A2K6DRW9; Macaca mulatta: H9Z6A2; Nomascus leucogenys: A0A2I3GCA7; Chlorocebus sabaeus: A0A0D9R3X6; Colobus angolensis palliatus: A0A2K5ILW0
It is possible new templates exist for this target since these models were created.
Available Structures
27 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structure of Human Polycomb Repressive Complex 2 (PRC2) with oncogenic histone H3K27M peptide |
Heteromer O75530; P68431; Q15022; Q92833; | 8×ZN; 1×SAH; | ||||
| Assess | ||||||
| PRC2-AEBP2-JARID2 bound to H2AK119ub1 nucleosome |
Heteromer O75530; P02281; P06897; P0CG48; P62799; P84233; Q09028; Q15022; Q6ZN18; Q92833; | 1×MG; 1×SAH; 1×ZN; | ||||
| Assess | ||||||
| Cryo-EM structure of PRC2 bound to cofactors AEBP2 and JARID2 in the Extended Active State |
Heteromer O75530; Q09028; Q15022; Q6ZN18; Q92833; | |||||
| Assess | ||||||
| Structure of Human Polycomb Repressive Complex 2 (PRC2) with inhibitor |
Heteromer O75530; Q15022; Q92833; | 8×ZN; 1×74D; | ||||
| Assess | ||||||
| Cryo-EM structure of PRC2 bound to cofactors AEBP2 and JARID2 in the Compact Active State |
Heteromer O75530; Q09028; Q15022; Q6ZN18; Q92833; | |||||
| Assess | ||||||
| Human Polycomb Repressive Complex 2 in complex with GSK126 inhibitor |
Heteromer O75530; Q15022; | 8×ZN; 1×A9G; | ||||
| Assess | ||||||
| G4 RNA-mediated PRC2 dimer |
Heteromer A0A6I9KXB3; O75530; Q09028; Q15022; Q6ZN18; | 14×ZN; | ||||
| Assess | ||||||
| Histone H3 recognition by nucleosome-bound PRC2 subunit EZH2. |
Heteromer P02281; P06897; P62799; P84233; Q15022; | 7×ZN; 1×SAH; | ||||
| Assess | ||||||
| Structure of Hs/AcPRC2 in complex with a pyridone inhibitor |
Heteromer G1KPH4; O75530; Q15022; | 1×6BN; 7×ZN; | ||||
| Assess | ||||||
| Crystal Structure of an EZH2-EED Complex in an Oligomeric State |
Heteromer O75530; | |||||
| Assess | ||||||
| EED in complex with PRC2 allosteric inhibitor compound 22 (MAK683) |
Heteromer O75530; | 3×CL; 1×EJR; | ||||
| Assess | ||||||
| EED in complex with PRC2 allosteric inhibitor compound 7 |
Heteromer O75530; | 2×CL; 1×EKF; | ||||
| Assess | ||||||
| EED in complex with PRC2 allosteric inhibitor compound 6 |
Heteromer O75530; | 2×CL; 1×EKR; | ||||
| Assess | ||||||
| EED in complex with PRC2 allosteric inhibitor EED162 |
Heteromer O75530; | 1×LQF; | ||||
| Assess | ||||||
| EED in complex with an allosteric PRC2 inhibitor EED666 |
Heteromer O75530; | 1×GOL; 1×LQB; | ||||
| Assess | ||||||
| Crystal structure of EED in complex with EZH2 peptide and compound 11# |
Heteromer O75530; | 1×EJU; | ||||
| Assess | ||||||
| EED in complex with PRC2 allosteric inhibitor EED709 |
Heteromer O75530; | 1×LQD; | ||||
| Assess | ||||||
| EED in complex with an allosteric PRC2 inhibitor |
Heteromer O75530; | 1×73K; | ||||
| Assess | ||||||
| EED in complex with PRC2 allosteric inhibitor compound 8 |
Heteromer O75530; | 1×LQG; | ||||
| Assess | ||||||
| EED in complex with PRC2 allosteric inhibitor compound 11 |
Heteromer O75530; | 1×LQH; | ||||
| Assess | ||||||
| Crystal structure of EED [G255D] in complex with EZH2 peptide and EED226 compound |
Heteromer O75530; | 1×GOL; 1×73K; | ||||
| Assess | ||||||
| EED in complex with PRC2 allosteric inhibitor EED210 |
Heteromer O75530; | 1×LQE; | ||||
| Assess | ||||||
| Crystal structure of EED in complex with H3K27Me3 peptide and 3-(benzo[d][1,3]dioxol-4-ylmethyl)pip… |
Heteromer O75530; | 1×7W7; | ||||
| Assess | ||||||
| Crystal structure of EED in complex with H3K27Me3 peptide and 6-(benzo[d][1,3]dioxol-4-ylmethyl)-5,… |
Heteromer O75530; | 1×GOL; 2×YT3; 1×7WD; | ||||
| Assess | ||||||
| Crystal Structure of Ubl123 with an EZH2 peptide |
Heteromer Q93009; | |||||
| Assess | ||||||
| Crystal structure of the EZH2 SET domain | monomer | 1×SO4; 6×ZN; | ||||
| Assess | ||||||
| Human Enhancer of Zeste (Drosophila) Homolog 2(EZH2) | monomer | 6×ZN; 4×UNX; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5hyn.1.A | monomer | 0.65 | 8×ZN; 1×SAH; | 100.00 | ||
| Assess | ||||||
6 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 5hyn.1.A | monomer | 0.65 | 8×ZN; 1×SAH; | 99.87 | |
| Assess | ||||||
| Isoform 3 | 5hyn.1.A | monomer | 0.64 | 8×ZN; 1×SAH; | 100.00 | |
| Assess | ||||||
| Isoform 3 | 5ij7.2.A | monomer | 0.59 | 7×ZN; | 90.89 | |
| Assess | ||||||
| Isoform 3 | 6u4y.1.B | monomer | 0.52 | 92.93 | ||
| Assess | ||||||
| Isoform 4 | 5hyn.1.A | monomer | 0.64 | 8×ZN; 1×SAH; | 100.00 | |
| Assess | ||||||
| Isoform 5 | 5hyn.1.A | monomer | 0.64 | 5×ZN; 1×SAH; | 99.86 | |
| Assess | ||||||